Business
Save Foods Stock Surges 128% After Nitrousink Acquisition
Save Foods Inc, a prominent agri-food tech leader, has made significant strides into the carbon credit and greenhouse gas emissions markets, solidifying its position with...
Nikola Stock Plunges Following New Shares Offering
Shares of Nikola Corporation took a nosedive, after the electric vehicle manufacturer unveiled its plans to issue $100 million in new shares and $200 million...
Bit Brother Stock Dips on $12.0 M Direct Offering Announcement
Bit Brother Ltd, a leading technology firm, witnessed a decline in its stock price following the announcement of a registered direct offering to sell a...
Treasury Yields Surge Amidst Heightened Speculation
In a whirlwind of global market activity, Treasury yields experienced an upward surge fueled by speculation that expectations of rate cuts by major central banks...
Labor Market Data Insights Drive Stocks to Surge
In a market-driven dance, US stocks took a bullish turn on Thursday as investors once again turned their attention to labor market data, seeking clues...
Stocks Close Lower as Oil Prices Sink to Lowest Since June
In a turbulent day for the US financial markets, stocks experienced a decline on Wednesday, influenced by fresh indicators of economic challenges such as oil...
Global Markets in Flux as Oil Prices Continue Descent
Oil prices experienced a continued descent on Wednesday, reaching a five-month low, despite the Energy Information Administration (EIA) releasing data indicating a 4.6 million-barrel decrease...
Rent the Runway Announces Q3 2023 Results, Stock Falls 23%
Rent the Runway, the groundbreaking shared designer closet platform, disclosed its financial performance for the fiscal third quarter (Q3) ending October 31, 2023, revealing a...
ImmunoPrecise Antibodies Stock Dips After Pricing Public Offering
In a move to bolster its financial standing, ImmunoPrecise Antibodies Ltd, a therapeutic antibody discovery company, announced today the pricing of its underwritten public offering,...
NeuroSense Therapeutics’ ALS Drug Trial Results Spur Stock Dip
NeuroSense Therapeutics, an Israeli clinical stage drug development company specializing in treatments for neurodegenerative diseases, revealed the results of its Phase 2b trial for the...
